WE ARE BILIM PHARMACEUTICAL
WE ARE BILIM PHARMACEUTICAL
Active Pharmaceutical Ingredients

About us

Bilim Pharmaceuticals stands as a global leader in the development and production of active pharmaceutical ingredients (APIs) for the CDMO and generic markets. With a strong base in Egypt, we integrate advanced chemical synthesis and biomanufacturing processes to meet and exceed international safety, quality, and environmental standards. Our commitment to excellence and innovation has established Bilim Pharmaceuticals as a prominent name in the API manufacturing sector, known for our dedication to advancing the pharmaceutical industry.

Regulatory Expertise

Quality Management

Technologies

Leading through biomanufacturing and chemical synthesis

Generic Active Pharmaceutical Ingredients (API)

Bilim Pharmaceuticals, a leading global supplier of Generic APIs, is renowned for its reliability and extensive experience in the pharmaceutical industry. Operating out of Istanbul, Turkey, we provide our partners with a robust commercial portfolio alongside an innovative R&D pipeline, designed to facilitate first-to-market generic products. Our commitment to delivering high-quality, cost-effective pharmaceutical solutions epitomizes our dedication to excellence.

Contract Development and Manufacturing Organization (CDMO) Services

At Bilim Pharmaceuticals, we specialize in the development and manufacturing of New Chemical Entities (NCEs) and advanced intermediates. Utilizing advanced technologies and processes, including chemical synthesis, microbial biomanufacturing, and semi-synthesis, we offer customized solutions that ensure rapid and precise market entry. Our operations adhere to stringent GMP standards, guaranteeing that all products meet the highest quality and regulatory benchmarks.

Regulatory Expertise

Olon Regulatory Affairs Department is a major asset and it has seen

Quality Management

Our Corporate QA has been designed to enhance synergies and develop best

Technologies

We constantly invest in our sites to upgrade the facilities in terms of GMP